Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Calls for Brucellosis vaccine after outbreak in India
The disease is a highly contagious zoonosis and can spread easily from animals to humans via unpasteurised milk and cheese from infected animals.
Expert says greater control is needed 

A brucellosis outbreak involving more than 50 cows in India has highlighted the need for greater disease control, experts say.

The latest outbreak occurred in the town of Tirumala in July and follows a similar outbreak in February, during which a dozen cows contracted the disease. The infected animals were segregated to prevent further infection.

It is estimated that 500,000 new human cases of brucellosis are reported annually across the globe. The World Health Organisation attributes around 400,000 of these cases to food-borne routes.

The disease is a highly contagious zoonosis and can spread easily from animals to humans via unpasteurised milk and cheese from infected animals.

Sascha Al Dahouk, scientific director at the German Federal Institute for Risk Assessment, says these cases serve as a reminder that an effective vaccine is needed to control the disease.

“We have these highly endemic regions where it's very important to introduce control. This control is mainly based, at the beginning, on vaccination. Afterwards, when it is controlled, surveying and culling is the better model, but at the beginning in the high endemic regions vaccination is definitely needed.”

He adds: “If you stop brucellosis in livestock, you definitely stop it in humans: this is the key.”

Brucellosis is endemic in a number of developing countries and can result in reduced productivity, costing smallholder farmers in South-East Asia and Sub-Saharan Africa around $500 million per year.

Further hotspots have also been found in the Mediterranean area and the Arabian Peninsula, according to Dr Al Dahouk.

“There are a lot of white spots on the map in Africa, some parts of South America where we do not know whether brucellosis is endemic – more specifically in goats and sheep, or in cattle.”

The AgResults Brucellosis Vaccine Development Prize is a $30 million competition to incentivise the creation of a new vaccine for Brucella melitensis in small ruminants across the developing world. Three prizes of $100,000 have already been awarded, and seven such prizes remain available in phase one of the competition, which closes on 18 November 2017.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.